Prognostic Impact of Persistent Measurable Residual Disease in Patients with Acute Myeloid Leukemia FLT3+ Treated with Intensive Chemotherapy Plus Midostaurin - a Retrospective Study of the Polish Adult Leukemia Group (PALG)Elżbieta Patkowska, Ewa Lech‐Marańda, Alicja Sadowska‐Klasa et al.|Blood|2022Cited by 0
KD-PACE chemotherapy regimen as a salvage therapy for aggressive, refractory multiple myelomaMaciej Dubaj, Marek Hus, Dorota Hawrylecka et al.|Acta Haematologica Polonica|2025Cited by 0